A bibliometric analysis of atezolizumab in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) is a highly prevalent primary liver cancer, accounting for over 90% of all liver cancer cases worldwide and ranking as the third leading cause of cancer-related deaths. The emergence of molecular targeted therapies has completely transformed the tre...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer
2025-10-01
|
| Seri Bilgileri: | Discover Oncology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s12672-025-03447-6 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|